Cardioprotection in Patients at High Risk of Anthracycline-Induced Cardiotoxicity: <i>JACC: CardioOncology</i> Primer.

Henriksen, Peter A; Rankin, Stephen; Lang, Ninian N

Cardioprotection in Patients at High Risk of Anthracycline-Induced Cardiotoxicity: JACC: CardioOncology Primer.

Henriksen, Peter A; Rankin, Stephen; Lang, Ninian N.

Afiliação

Henriksen PA; BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom.
Rankin S; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, United Kingdom.
Lang NN; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, United Kingdom.

JACC CardioOncol ; 5(3): 292-297, 2023 Jun.

Article em En | MEDLINE | ID: mdl-37397086

Palavras-chave

anthracycline; breast cancer; cancer survivorship; cardiomyopathy; heart failure; prevention

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Revista: JACC CardioOncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google